VOYA Investment Management
CRVS icon

VOYA Investment Management’s Corvus Pharmaceuticals CRVS Stock Holding History

VOYA Investment Management’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.46M Buy
99,631
+71,970
+260% +$1.15M ﹤0.01% 1326
2025
Q4 		$213K Buy
+27,661
New +$218K ﹤0.01% 2125
2025
Q3 		– Sell
-14,774
Closed -$59.1K – 2489
2025
Q2 		$59.1K Buy
+14,774
New +$53.8K ﹤0.01% 2572

Other funds holding CRVS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VOYA Investment Management's CRVS Position: Q1 2026 in Review

VOYA Investment Management increased its Corvus Pharmaceuticals (CRVS) stake by 260% in Q1 2026, buying an estimated $1.15M and bringing the position to 99,631 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1326.

VOYA Investment Management first reported a position in CRVS in Q2 2025 and has held it in 3 quarters since. 164 funds tracked by Wall St. Rank hold CRVS as of Q1 2026.

  • VOYA Investment Management held 99,631 shares of Corvus Pharmaceuticals worth $1.46M as of Q1 2026.
  • VOYA Investment Management bought 71,970 Corvus Pharmaceuticals shares in Q1 2026, an estimated $1.15M.
  • Corvus Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1326 holding.
  • VOYA Investment Management first reported a position in Corvus Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 164 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.